RBC Europe’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4
| Closed | -$533 | – | 1196 |
|
|
2020
Q3 | $533 | Hold |
4
| – | – | ﹤0.01% | 1050 |
|
|
2020
Q2 | $675 | Hold |
4
| – | – | ﹤0.01% | 1009 |
|
|
2020
Q1 | $575 | Hold |
4
| – | – | ﹤0.01% | 980 |
|
|
2019
Q4 | $1.32K | Hold |
4
| – | – | ﹤0.01% | 978 |
|
|
2019
Q3 | $2K | Hold |
4
| – | – | ﹤0.01% | 967 |
|
|
2019
Q2 | $2.43K | Hold |
4
| – | – | ﹤0.01% | 972 |
|
|
2019
Q1 | $2.44K | Hold |
4
| – | – | ﹤0.01% | 988 |
|
|
2018
Q4 | $1.46K | Hold |
4
| – | – | ﹤0.01% | 1013 |
|
|
2018
Q3 | $2.7K | Hold |
4
| – | – | ﹤0.01% | 1029 |
|
|
2018
Q2 | $3.48K | Hold |
4
| – | – | ﹤0.01% | 1011 |
|
|
2018
Q1 | $5.03K | Hold |
4
| – | – | ﹤0.01% | 944 |
|
|
2017
Q4 | $5.98K | Hold |
4
| – | – | ﹤0.01% | 923 |
|
|
2017
Q3 | $8.19K | Buy |
+4
| New | +$8.19K | ﹤0.01% | 878 |
|